MJA 222 3 17 Feb cover

Issues

Volume 222 Issue 3

17 February 2025

Cover image credit: StunningArt/Shutterstock.com

Editor’s choice

From the MJA 17 February 2025 Free

Addressing inequality of health care

Inequality in access to health services and the rising cost of the health system are both challenges to the Australian health system (https://www.health.gov.au/about‐us/the‐australian‐health‐system). A number of articles in this issue of the MJA are relevant to describing the nature of these challenges and how they may be addressed. The National Disability Insurance Scheme (NDIS) replaced a disability care system that was inequitable and provided limited choice and access to appropriate support. The self‐directed nature of the NDIS is designed to, at least in part, overcome these limitations and address deeply rooted barriers that hinder people with disability from fully engaging in society. In this issue, Disney and colleagues used NDIS data to quantify the inequalities in the allocation and use of NDIS support (https://doi.org/10.5694/mja2.52594). They found that older applicants, those who are women or girls, and those living in socio‐economically disadvantaged areas are less likely to be deemed eligible for the NDIS. As Smith‐Merry and Chang note in their associated editorial (https://doi.org/10.5694/mja2.52587), inequality of access is linked to social inequities, in addition to providing guidance for future research to inform a more tailored and inclusive approach to support provision. Obesity is a major contributor to the burden of disease in Australia and is strongly linked with social inequalities and disadvantage. After the failure of so many previous anti‐obesity medications (https://journals.biologists.com/dmm/article/5/5/621/3257/Anti‐obesity‐drugs‐past‐present‐and‐future), the glucagon‐like peptide‐1 (GLP‐1) receptor agonists provide perhaps a glimpse of light at the end of the tunnel. Supported by strong evidence of both weight loss and broader health benefits, and amidst a wave of viral celebrity engagement, their worldwide usage has skyrocketed. Within this context, Kanellis and colleagues discuss the role of GLP‐1 receptor agonists in obesity (https://doi.org/10.5694/mja2.52582), with a specific focus on identifying funding models and models of care relevant for Australia. By addressing these challenges, the potential of GLP‐1 receptor agonists to revolutionise obesity care in a sustainable and equitable manner can be fully realised. There are also challenges on the individual level for patients. The decline in bulk‐billing by general practitioners and the current cost of living crisis have affected affordability of health care for many people. Through analysis of Medicare bulk‐billing rates and out‐of‐pocket costs for non‐bulk‐billed general practitioner services, Saxby and Zhang highlight the differences in access to affordable health care on the basis of geographic region, with those in remote and socio‐economically disadvantaged areas of Australia having the highest out‐of‐pocket costs (https://doi.org/10.5694/mja2.52562). In their associated editorial, Rosenberg and Hickie describe three issues that require redress to improve the system to a level of fairness expected by the average Australian (https://doi.org/10.5694/mja2.52580). And finally, a medical history article that has less to do with modern challenges to the health care system, but rather provides a glimpse of health care challenges under extreme circumstances. Ariotti and Roberts‐Pederson present a fascinating look at the diaries written from inside the Changi prison camp complex by prisoner‐of‐war Australian medical officer Major Kennedy Burnside (https://doi.org/10.5694/mja2.52581). For the thousands of his fellow prisoners‐of‐war in Changi, his work there played an important role in minimising the impact of their living conditions on their health. Key aspects of his work highlighted include the diagnosis, treatment and prevention of malaria and the development of a dysentery vaccine. The photos that accompany the article, taken by Burnside, provide an insight into the nature of the pathology laboratory that he established and an intriguing glimpse of life within the complex. I would recommend readers to take the time to view the full collection available on the Australian War Memorial website. In one thought‐provoking section, the authors detail how Major Burnside pondered whether his endeavours while a prisoner‐of‐war would have any relevance to his post‐war career; he went on to have an illustrious career in medicine. Irrespective of his post‐war career achievements, the value of what he did in that period, under those circumstances, cannot be overstated. In the words of Ralph Waldo Emerson, “The reward of a thing well done, is to have done it”.

Michael Skilton

Perspective

Genetics 3 February 2025 Free

Genetic counsellors: facilitating the integration of genomics into health care

A discussion on challenges in implementing genomic medicine in Australia and the role of genetic counsellors, their training and relevant skill sets. Evidence for their impact on patient care, clinicians and health services is also reviewed, with barriers to widespread facilitation.

Tatiane Yanes · Eliza Courtney · Mary‐Anne Young · Amy Pearn · Aideen McInerney‐Leo · Jodie Ingles

Metabolic diseases 17 February 2025 Free

The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system

The use of glucagon-like peptide-1 receptor agonists in the treatment of obesity has the potential to impact one-third of Australians. This warrants due consideration and planning for future funding models, systems and models of care to ensure equitable access

Christopher Kanellis · Kyle Williams · Darcy Q Holt · Jennifer Wong · Rachel David · Ravi Carothers · Suong Le

Medical education

Infectious diseases 3 February 2025 Lessons from practice Free

Human case of diphyllobothriasis in Australia

In 2024, a 30-year-old female resident of Melbourne, Australia, with no past medical history presented to the Royal Melbourne Hospital

Sadid F Khan · Anson V Koehler · Alistair Tinson · Maidhili Chinnappan · Harsha Sheorey · Robin B Gasser

Medical history

Erratum

17 February 2025 Free

Erratum

Macintyre PE, Jamcotchian MA, Stevens JA. Calling time on the use of modified‐release opioids for acute pain. Med J Aust 2024; https://doi.org/10.5694/mja2.52417 Requirements for individualised opioid titration regimens The opioid prescription The initial dose range of opioid prescribed should vary according to the age of the patient (for opioid‐naïve patients) and the severity of the anticipated pain: ‣ Age is a better predictor of opioid requirements than patient weight ‣ Increasing age is associated with decreased opioid requirements and this appears to be primarily due to pharmacodynamic rather than pharmacokinetic factors; that is, increased sensitivity of the central nervous system with ageing rather than the changes in metabolism and excretion of the drug that might also be seen in older patients ‣ The initial opioid dose range prescribed should be lower in patients with moderate pain than those with severe acute pain; lower doses may also be safer where appropriate monitoring is not reliable Subsequent doses may need to be adjusted according to patient response (analgesic effectiveness and adverse effects) Prescribe an appropriate dose interval (the interval within which additional doses should not be given): ‣ In some settings (eg, where there is 24‐hour medical cover and experienced nursing staff and appropriate monitoring are available) it may be reasonable to order an IR opioid “every two hours as needed”; in other settings “every four hours as needed” may be safer Order “as needed” only and not on a regular (time‐contingent) basis; write maximum 24‐hour dose as “sedation score less than 2” Coprescription of naloxone is suggested The IR opioid should be used for the shortest time possible and in decreasing doses over a short time. Deprescribing starts in hospital and requires involvement of nurses, doctors, ward pharmacists and the patient: ‣ This requires regular patient review ‣ The opioid prescription may need to be rewritten to allow for or assist with decreasing opioid dose trajectories, sometimes on a daily basis Assessment of analgesic effectiveness Unidimensional pain scores are commonly used in the acute pain setting to determine analgesic effectiveness and guide opioid titration: ‣ Do not adjust analgesic regimens, including opioid doses, based on a patient's pain scores alone ‣ Predictors of high pain scores include psychological comorbid conditions (eg, anxiety, catastrophising), pre‐existing chronic pain, and tolerance to opioids, and therefore high scores do not always mean that an opioid — or more opioid — is needed ‣ A patient's pain score trajectory (plotting a patient's pain scores over time) is a more useful indicator of patient progress and can allow identification of psychological distress, the presence of non‐opioid‐responsive pain and post‐operative/post‐trauma complications; pain score trajectories that do not decrease over the first few days are also good predictors of chronic post‐surgical pain. Patients whose pain score trajectories are not decreasing require review ‣ “Chasing” pain scores with opioids to achieve an arbitrarily defined acceptable level of pain or zero pain can lead to increases in the risk of OIVI and PPOU Include an assessment of patient function (eg, using functional activity scores). One example of a functional activity score is: A — no limitation of relevant activity due to pain (relative to baseline) B — mild limitation of activity due to pain C — unable to complete activity due to pain Recognition of OIVI Increasing sedation is a more reliable indicator of developing OIVI than a decrease in respiratory rate: ‣ Respiratory rate can remain within acceptable limits even when OIVI is severe ‣ Record sedation scores (along with pain scores and functional activity scores) at time of administration of the IR opioid and when peak effect is expected (ie, about one hour after administration of an oral IR opioid) One suggested sedation scoring system is: 0 = wide awake, 1 = easy to rouse (and can stay awake), 2 = easy to rouse but unable to remain awake, and 3 = difficult to rouse: ‣ Titrate opioids so that sedation score is always <2 Hypoxaemia may be a very late sign of hypoventilation, especially if the patient is receiving supplemental oxygen Immediate intervention is required if a patient has a sedation score of 2 or 3, regardless of the patient's respiratory rate doi: 10.5694/mja2.52417

Editorial

Research

Research letter

Next Issue Volume 222 Issue 4

View more
MJA 222 4 3 Mar cover
Perspective 3 March 2025 Open Access

Improving palliative care for people who use alcohol and other drugs

Grace FitzGerald · Jon Cook · Peter Higgs · Charles Henderson · Sione Crawford · Thileepan Naren

Perspective 3 March 2025 Open Access

Decentralised COVID‐19 molecular point‐of‐care testing: lessons from implementing a primary care‐based network in remote Australian communities

Belinda Hengel · Rebecca J Guy · Dawn Casey · Lorraine Anderson · Kirsty Smith · Kelly Andrewartha · Tanya D Applegate · Amit Saha · Philip Cunningham · Lucas DeToca · William D Rawlinson · Marianne Martinello · Annie Tangey · Prital Patel · Mark DS Shephard · Susan Matthews · Louise Causer

Previous Issue Volume 222 Issue 2

View more
MJA 222 2 3 Feb cover
Editor's choice 3 February 2025 Free

Policy responses to climate crisis and health in Australia: a need for urgency

Elizabeth Zuccala

Perspective 13 January 2025 Free

Japanese encephalitis transmission in Australia: challenges and future perspectives

Caroline K Dowsett · Francesca Frentiu · Gregor J Devine · Wenbiao Hu

Perspective 16 December 2024 Free

Making climate change a national health priority: Australia's first National Health and Climate Strategy

Georgia Behrens · Madeleine Skellern · Alice McGushin · Paul Kelly · The Hon Ged Kearney

Perspective 27 January 2025 Free

Is the term bulk‐billing still relevant in today's landscape of health policy reform?

Michael Wright · May Chin

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.